24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
With scientific advice to the government scrutinized in the news during the COVID-19 pandemic, population biologist Professor Sir Charles Godfray focused the final lecture of the Green Templeton Lecture series 2022 on the different ways experts provide advice in the public realm. Oxford PharmaGenesis Associate Medical Writer Luke Bratton and Communications Director Tim Koder report.
The 18th European AIDS Conference (EACS 2021) brought together clinicians, researchers and people living with HIV to share and discuss some of the latest developments in the treatment and management of HIV, viral hepatitis, tuberculosis and COVID-19 from around the globe.
In the second lecture of the Green Templeton Lectures 2022, award-winning Indian television journalist Barkha Dutt explored the inequalities and journalistic flaws that COVID-19 exposed in India. Oxford PharmaGenesis Project Coordinator Holly Hickman and Group Communications Director Paul Farrow report on Dutt’s powerful series of personal stories. ‘Hell and back: on the road with the…
In the first lecture of the Green Templeton Lectures 2022, international media manager and journalist Wolfgang Blau addressed the urgent need for newsrooms to improve how they report on climate change. Oxford PharmaGenesis Associate Medical Writer, Elizabeth Coe, took the opportunity to attend the event and report back.
Share this page From AI to CSR: leading the conversation at the Virtual 2022 European Meeting of ISMPP The changing publications landscape, cross-functional collaboration and artificial intelligence (AI) were all on the agenda at the Virtual 2022 European Meeting of ISMPP, as Oxford PharmaGenesis led conversations on some of the most compelling issues affecting the…
Together we can explore the latest opportunities in publications, medical affairs, informatics and patient engagement.
If you are ready to explore new frontiers, Oxford PharmaGenesis is ready to help.
